These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18309935)

  • 1. In vivo tomographic imaging studies of neurodegeneration and neuroprotection: a review.
    Waterhouse RN; Zhao J
    Methods Mol Biol; 2007; 399():215-33. PubMed ID: 18309935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target-specific PET probes for neurodegenerative disorders related to dementia.
    Kadir A; Nordberg A
    J Nucl Med; 2010 Sep; 51(9):1418-30. PubMed ID: 20810758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection and imaging studies in Parkinson's disease.
    Pavese N; Kiferle L; Piccini P
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S33-7. PubMed ID: 20123554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear medicine imaging in neurodegenerative dementias].
    Gratz S; Hahn U; Kaiser JW; Jarnig M; Schwarz J; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S5-7. PubMed ID: 18437639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal syndromes: PET and SPECT.
    Tatsch K
    Neuroimaging Clin N Am; 2010 Feb; 20(1):57-68. PubMed ID: 19959018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of neurotransmission and brain receptors in dementia.
    Pappatà S; Salvatore E; Postiglione A
    J Neuroimaging; 2008 Apr; 18(2):111-24. PubMed ID: 18380693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/SPECT imaging agents for neurodegenerative diseases.
    Zhu L; Ploessl K; Kung HF
    Chem Soc Rev; 2014 Oct; 43(19):6683-91. PubMed ID: 24676152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular targets for PET and SPECT imaging in neurodegenerative diseases.
    Benadiba M; Luurtsema G; Wichert-Ana L; Buchpigel CA; Busatto Filho G
    Braz J Psychiatry; 2012 Oct; 34 Suppl 2():S125-36. PubMed ID: 23429844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective neuroimaging in vivo.
    Smith DF; Jakobsen S
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):507-22. PubMed ID: 17368004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Trends and Current Status of Positron-Emission Tomography and Single-Photon-Emission Computerized Tomography Radioligands for Neuronal Serotonin Receptors and Serotonin Transporter.
    Hazari PP; Pandey A; Chaturvedi S; Mishra AK
    Bioconjug Chem; 2017 Nov; 28(11):2647-2672. PubMed ID: 28767225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers.
    Shah M; Catafau AM
    J Nucl Med; 2014 Jun; 55(6):871-4. PubMed ID: 24833492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
    Chugani HT
    Pediatr Neurol; 2019 Nov; 100():12-25. PubMed ID: 31416725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging diagnosis in neurodegenerative diseases.
    Szymański P; Markowicz M; Janik A; Ciesielski M; Mikiciuk-Olasik E
    Nucl Med Rev Cent East Eur; 2010; 13(1):23-31. PubMed ID: 21154313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT imaging in dementia.
    Pimlott SL; Ebmeier KP
    Br J Radiol; 2007 Dec; 80 Spec No 2():S153-9. PubMed ID: 18445745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative positron emission tomography in brain research.
    Heurling K; Leuzy A; Jonasson M; Frick A; Zimmer ER; Nordberg A; Lubberink M
    Brain Res; 2017 Sep; 1670():220-234. PubMed ID: 28652218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities.
    Zürcher NR; Bhanot A; McDougle CJ; Hooker JM
    Neurosci Biobehav Rev; 2015 May; 52():56-73. PubMed ID: 25684726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future Directions in Molecular Imaging of Neurodegenerative Disorders.
    Barthel H; Villemagne VL; Drzezga A
    J Nucl Med; 2022 Jun; 63(Suppl 1):68S-74S. PubMed ID: 35649650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advance of SPECT: differential diagnosis and evaluation of pathophysiology of neurodegenerative disorders].
    Kuwabara Y
    Rinsho Shinkeigaku; 2004 Nov; 44(11):894-6. PubMed ID: 15651324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.